SAN FRANCISCO, CA – (August 14, 2019) – Revive Solutions, Inc. (“Revive” or the “Company”), a leading developer of a next-generation Automated External Defibrillator (“AED”) addressing the global public health issue of Sudden Cardiac Arrest (“SCA”), today announced that Sheela Bhandarkar has joined the Company as its Design Assurance Engineering Manager, and Dan Galkowski has joined the Company as its Software Architect.
Sheela has more than 10 years of experience in R&D and Design quality roles in which she developed Class II and Class III medical devices. Before joining Revive Solutions, she most recently had a leadership role in Design Quality Engineering for drug catheter balloons at Philips IGT. From small start-ups and large corporations, Sheela has taken conceptualized products to the commercialization phase.
“I am thrilled to join this team of passionate and innovative leaders who are combining disruptive technology and medical innovation to develop next generation AEDs,” Sheela explained. “I’m highly motivated to take on the challenge of bringing this cutting-edge device to the market and ensuring we deliver a safe, highly effective, and superior product to our customers.”
With over 30 years of experience as a software developer, Dan has worked in industries ranging from banking to medical devices. Before starting at Revive Solutions, he was the Principal Software Engineer of CRISI Medical Systems (acq. by Becton Dickinson).
“I’m excited to be a part of this innovative team and to have the opportunity to personally contribute to saving lives through improved technology. This team has high standards and works collaboratively guaranteeing success. I look forward to the challenge of building the infrastructure that will help mold the future of the AED industry,” said Dan.
About Avive Solutions, Inc. (Previously known as Revive Solutions, Inc.)
Avive Solutions, Inc is a San Francisco-based privately-held healthcare technology company developing a next-generation automated external defibrillator and software solutions in an effort to significantly increase survival rates from Sudden Cardiac Arrest.